Orphan diseases

Interstitial pneumonia with autoimmune features (IPAF): the relationship between radiological and clinical features
Victoria Sholomova, Larisa Akulkina, Michael Brovko, Alisa Yanakaeva, Denis Konovalov, Sergey Moiseev

European Respiratory Journal Sep 2020, 56 (suppl 64) 761; DOI: 10.1183/13993003.congress-2020.761
KL-6 as a potential therapeutic biomarker in fibrosing interstitial lung diseases
Vivien Somogyi, Katharina Mayer, Katharina Kriegsmann, Mark Kriegsmann, Peter Findeisen, Michael Kreuter

European Respiratory Journal Sep 2020, 56 (suppl 64) 820; DOI: 10.1183/13993003.congress-2020.820
Consistent effect of nintedanib on reducing FVC decline across interstitial lung diseases (ILDs)
Francesco Bonella, Toby M. Maher, Vincent Cottin, Claudia Valenzuela, Marlies Wijsenbeek, Florian Voss, Klaus B. Rohr, Susanne Stowasser

European Respiratory Journal Sep 2020, 56 (suppl 64) 739; DOI: 10.1183/13993003.congress-2020.739
European Cystic Fibrosis Society Clinical Trials Network (ECFS-CTN): structure and impact since 2009
Silke Van Koningsbruggen-Rietschel, Damian G. Downey, Lieven Dupont, Fiona Dunlevy, Veerle Bulteel, Kate Hayes, Nick Simmonds, Nadine Dufeu, Hettie M. Janssens, Dorota Sands, Paola De Carli, Isabelle Sermet-Gaudelus, Kris De Boeck, Tim Lee, Isabelle Fajac

European Respiratory Journal Sep 2020, 56 (suppl 64) 367; DOI: 10.1183/13993003.congress-2020.367
Study of IPF relatives as a method of early diagnosis of ILD disease
Olaia Bronte Moreno, Myriam Aburto, Amaia Urrutia, Carmen Jaca, Maria Iciar Arrizubieta, Miren Begoñe Salinas, Laura Tomás, Iñaki Salegui

European Respiratory Journal Sep 2020, 56 (suppl 64) 447; DOI: 10.1183/13993003.congress-2020.447
Assessment of clinical and instrumental efficacy of Expiratory Flow Accelerator technology in patients with Primary Ciliary Diskinesia
Alessia Masciave', Silvano Dragonieri, Enza Pentassuglia, Paola Giordano, Luigi Mappa

European Respiratory Journal Sep 2020, 56 (suppl 64) 394; DOI: 10.1183/13993003.congress-2020.394
Epidemiology and mortality of non-idiopathic pulmonary fibrosis (IPF) progressive fibrosing interstitial lung disease (PF-ILD) using the French national health insurance system (SNDS) database in France: the PROGRESS study
Mouhamad Nasser, Sophie Larrieu, Loïc Boussel, Salim Si-Mohamed, Fabienne Diaz, Sébastien Marque, Jacques Massol, Didier Revel, Francoise Thivolet-Bejui, Lara Chalabreysse, Delphine Maucort-Boulch, Vincent Cottin

European Respiratory Journal Sep 2020, 56 (suppl 64) 444; DOI: 10.1183/13993003.congress-2020.444
A cohort of patients with a progressive fibrosing phenotype of interstitial lung disease (PF-ILD) other than idiopathic pulmonary fibrosis (IPF): the PROGRESS study
Mouhamad Nasser, Sophie Larrieu, Salim Si-Mohamed, Kais Ahmad, Loïc Boussel, Marie Brevet, Lara Chalabreysse, Céline Fabre, Sébastien Marque, Didier Revel, Francoise Thivolet-Bejui, Julie Traclet, Sabrina Zeghmar, Delphine Maucort-Boulch, Vincent Cottin

European Respiratory Journal Sep 2020, 56 (suppl 64) 440; DOI: 10.1183/13993003.congress-2020.440
Quantification of circulating alpha-1-antitrypsin polymers in dried blood spots
Ilaria Ferrarotti, Stefania Ottaviani, Mattia Laffranchi, Valentina Barzon, Alice Maria Balderacchi, Guido Levi, Angelo Guido Corsico, Luciano Corda, Federica Benini, Anna Maria Fra

European Respiratory Journal Sep 2020, 56 (suppl 64) 326; DOI: 10.1183/13993003.congress-2020.326
Allergy in patients with lymphangioleiomyomatosis
Elżbieta Radzikowska, Joanna Nowacka-Ejsmont, Joanna Miłkowska-Dymanowska, Elzbieta Wiatr, Katarzyna Błasinska, Adriana Rozy, Miquel Angel Pujana

European Respiratory Journal Sep 2020, 56 (suppl 64) 241; DOI: 10.1183/13993003.congress-2020.241

Main menu

User menu

Search

Orphan diseases

Pages

Contact us